Literature DB >> 7840343

Allometry of pharmacokinetics and pharmacodynamics of the muscle relaxant metocurine in mammals.

G A Gronert1, D L Fung, J H Jones, S L Shafer, S V Hildebrand, E A Disbrow.   

Abstract

We investigated the effects of body size on the pharmacokinetics and pharmacodynamics of the renally cleared muscle relaxant metocurine. We hypothesized that pharmacokinetics of the drug would change allometrically in proportion to physiological time [infinity Mb0.25, where Mb is body mass] and that pharmacodynamics would be independent of size because of the highly conserved structure of the acetylcholine receptor. Metocurine effects during general anesthesia were examined in 17 rats, 8 cats, 6 dogs, 5 pigs, 7 sheep, and 12 horses. Allometric analysis demonstrated size dependence for pharmacokinetics, which were affected by physiological time (Mb0.25). Pharmacodynamics were size independent, except for the value for effect compartment concentration associated with 50% twitch paralysis (IC50). Data from individual species had a bimodal distribution that was significant: pigs and sheep were more sensitive than other large species, and their IC50 appeared size independent. IC50 was size dependent in more active species (horse, dog, cat, rat). Although the mechanism is unknown, we speculate that this trend might relate to receptor density within the end plate. Thus pharmacokinetics changed in proportion to physiological time, and pharmacodynamics were in part size independent.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7840343     DOI: 10.1152/ajpregu.1995.268.1.R85

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Scaling the time-course of myelosuppression from rats to patients with a semi-physiological model.

Authors:  Lena E Friberg; Marie Sandström; Mats O Karlsson
Journal:  Invest New Drugs       Date:  2009-08-27       Impact factor: 3.850

2.  Allometric scaling of pharmacodynamic responses: application to 5-Ht1A receptor mediated responses from rat to man.

Authors:  Klaas P Zuideveld; Piet H Van der Graaf; Lambertus A Peletier; Meindert Danhof
Journal:  Pharm Res       Date:  2007-05-31       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.